	US 7,550,440 B2
	Topical application of ivermectin for the treatment of dermatological conditions/afflictions
Vincent Manetta, Bordentown, N.J. (US); and Gary R. Watkins, Piscataway, N.J. (US)
Assigned to Galderma S.A., Cham (Switzerland)
Filed on Oct. 24, 2005, as Appl. No. 11/255,910.
Application 11/255910 is a continuation of application No. PCT/EP2004/004950, filed on Apr. 22, 2004.
Claims priority of provisional application 60/468994, filed on May 09, 2003.
Claims priority of application No. 03 05048 (FR), filed on Apr. 24, 2003.
Prior Publication US 2006/0100165 A1, May 11, 2006
Int. Cl. A61K 31/70 (2006.01)

U.S. Cl. 514—30

4 Claims

1. A regime or regimen for the treatment of rosacea, comprising topically applying onto the affected skin area of an individual in need of such treatment, the topical pharmaceutical emulsion which comprises:


	Ivermectin	1.00
	Glycerol	4.0
	Acrylate C10-30 alkyl acrylate	0.2
	crosspolymer
	Methyl para-hydroxybenzoate	0.2
	Disodium EDTA	0.05
	Citric acid monohydrate	0.05
	Isopropyl palmitate	4.0
	Cetyl alcohol	3.5
	Stearyl monostearate	2.5
	Oleyl alcohol	2.0
	Ceteareth-20	3.0
	Sorbitan monostearate	2.0
	Dimethicone 200 20 cs	0.5
	Propyl para-hydroxybenzoate	0.1
	Propylene glycol	2.0
	Phenoxyethanol	1.0
	10% sodium hydroxide	qs pH
	Water	qs 100

as % by weight relative to the total weight of the emulsion.